SCHEMBL16475795

SCHEMBL16475795

c1ccc(-n2c3ccccc3c3cc(-c4ccc5c(c4)c4ccccc4n5-c4cc(-c5ccc(-c6ccc7ccccc7c6)cc5)c5ccccc5n4)ccc32)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
ATM Q13315 1/20 0.41
EGFR P00533 1/20 0.41
ALDH1A1 P00352 4/20 0.40
HPGD P15428 3/20 0.40
TDP1 Q9NUW8 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40
LMNA P02545 2/20 0.38
HTT P42858 2/20 0.38
PTGER4 P35408 1/20 0.37
MAPK1 P28482 2/20 0.37
MAPT P10636 1/20 0.37
ACACA Q13085 2/20 0.36
TUBB4A P04350 1/20 0.35
TUBB P07437 1/20 0.35
TUBA3C P0DPH7 1/20 0.35
TUBA1B P68363 1/20 0.35
TUBA4A P68366 1/20 0.35
TUBB4B P68371 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19271587 0.97 KDM4E (0.42) KDM4EL3MBTL1ATMEGFRALDH1A1
SCHEMBL14979609 0.93 EGFR (0.47) KDM4EL3MBTL1ATMEGFRALDH1A1
SCHEMBL14979344 0.92 EGFR (0.48) KDM4EL3MBTL1ATMEGFRALDH1A1
SCHEMBL16706424 0.90 EGFR (0.44) KDM4EL3MBTL1ATMEGFRALDH1A1
SCHEMBL15682599 0.90 EGFR (0.44) KDM4EL3MBTL1ATMEGFRALDH1A1
SCHEMBL16706427 0.90 EGFR (0.44) KDM4EL3MBTL1ATMEGFRALDH1A1
SCHEMBL16706428 0.90 EGFR (0.46) KDM4EL3MBTL1ATMEGFRALDH1A1
SCHEMBL14979061 0.88 KDM4E (0.43) KDM4EL3MBTL1ATMEGFRALDH1A1
SCHEMBL16706429 0.88 KDM4E (0.43) KDM4EL3MBTL1ATMEGFRALDH1A1
SCHEMBL15589133 0.88 KDM4E (0.45) KDM4EL3MBTL1ATMEGFRALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9287512-B2 Organic electroluminescent compounds, layers and organic electroluminescent device using the same ROHM AND HAAS ELECTRONIC MATERIALS KOREA LTD. (KR) 2016-03-15 US disclosed
US-20150357583-A1 Novel Organic Electroluminescent Compounds, Layers and Organic Electroluminescent Device Using The Same DUPONT SPECIALTY MATERIALS KOREA LTD (KR) 2015-12-10 US disclosed
US-20150357583-A1 Novel Organic Electroluminescent Compounds, Layers and Organic Electroluminescent Device Using The Same DUPONT SPECIALTY MATERIALS KOREA LTD (KR) 2015-12-10 US disclosed
US-20150171346-A1 Novel Organic Electroluminescent Compounds and Organic Electroluminescent Device Using The Same ROHM & HAAS ELECT MAT (KR) 2015-06-18 US disclosed
US-20150171346-A1 Novel Organic Electroluminescent Compounds and Organic Electroluminescent Device Using The Same ROHM & HAAS ELECT MAT (KR) 2015-06-18 US disclosed
US-20140107338-A1 NOVEL ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME Rohm, and Haas Electronic Materials Korea Ltd. (KR) 2014-04-17 US disclosed
US-20140107338-A1 NOVEL ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME Rohm, and Haas Electronic Materials Korea Ltd. (KR) 2014-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150171346-A1 Novel Organic Electroluminescent Compounds and Organic Electroluminescent Device Using The Same OR10J3, VDAC2, KCNN2 KDM4E 826/4885L3MBTL1 910/4885ATM 4249/4885
US-20140107338-A1 NOVEL ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME OR10J3, VDAC2, KCNN2 KDM4E 826/4885L3MBTL1 910/4885ATM 4249/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.